- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02031315
Epidemiology of Sudden Death in Cameroon (DOUALA-SD)
January 9, 2014 updated by: BONNY Aimé, Cameroon Resuscitation Council
Sudden Death in Sub-Saharan Africa: Design and Protocol of The DOUALA-SD Prospective Survey
Background The burden of sudden death (SD) in sub-Saharan Africa is unknown.
The aim is to assess the incidence, etiology and patient characteristics of SD in a sub-Saharan country.
Methods The Douala-SD study is a prospective, multicenter, community-based registry monitoring all cases of SD occurring in index areas of Douala city.
Investigators will use the definition of SD as natural death occurring within 24h at the onset of symptoms.
Demographic, clinical, electrocardiographic and biological variables (when available) of victims will be recorded.
All deaths occurring in residents of health areas of interest will be checked for past medical history, circumstances of death, and autopsy (if possible).
Conclusion This maiden Douala-SD study will provide comprehensive, contemporary data on the epidemiology of SD in a sub-Saharan African country and will help in the development of strategies to prevent and manage SD in Africa.
Study Overview
Status
Unknown
Conditions
Detailed Description
Two health areas were excluded for inaccurate data collection, and 2 other were randomly disqualified as investigators previously decided to conduct the survey in ≤ 4 areas.
The mode of randomization aimed at includes no more than 1 health area per district.
Finally, investigators retained 4 health areas representing 4 out of 6 districts of Douala.
Thus, the sampling of 240,384 inhabitants will be monitored prospectively.
All administrative staff and community-healthcare committee, the so-called " comité de santé" (COSA) of each health area will be a key component of the research team, helping identify every case of death in the area of concern.
Every case of death will be reported by the staff of COSA in a specific questionnaire form.
In addition to the deaths noted by members of each COSA, investigators will pay attention with all notices of deaths in local newspapers, radio, interrogation of health area residents, and death certificates from local medical centers.
Study Type
Observational
Enrollment (Anticipated)
240000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aimé BONNY, MD
- Phone Number: +33637975227
- Email: aimebonny@yahoo.fr
Study Contact Backup
- Name: Robinson ATEH, MsC
- Phone Number: +23775758101
- Email: robdj2005@yahoo.com
Study Locations
-
-
-
Douala, Cameroon
- Recruiting
- Cameroon Resuscitation Council
-
Sub-Investigator:
- Robinson ATEH, MsC
-
Principal Investigator:
- Aime Bonny, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
First, the subject must be a permanent resident of one of 4 'health areas' included in the study.
Second, each district of interest must have an updated population census.
Description
Inclusion Criteria: All witnessed and unwitnessed victims of unexpected natural death
-
Exclusion Criteria:
- Victims living in the area of interest for a short time frame (< 12 months)
- Absence of information helping to determine circumstances of death
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Resident of health areas of interest
Residents of 4 health areas will be monitored for sudden unexpected death within 72 months of follow up.
Circumstances and past medical conditions will be checked.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Sudden death, either cardiac or non-cardiac origin
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Aimé BONNY, MD, Teaching Hospital Laquintinie, University of Douala, Cameroon
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Arthur JT. Sudden deaths: cardiac and non-cardiac in children in Accra. West Afr J Med. 1995 Apr-Jun;14(2):108-11.
- Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA. Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria. Vasc Health Risk Manag. 2013;9:333-9. doi: 10.2147/VHRM.S44923. Epub 2013 Jun 24.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Anticipated)
December 1, 2014
Study Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
January 7, 2014
First Submitted That Met QC Criteria
January 7, 2014
First Posted (Estimate)
January 9, 2014
Study Record Updates
Last Update Posted (Estimate)
January 13, 2014
Last Update Submitted That Met QC Criteria
January 9, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRC-SD 2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States